AGT (Angiotensinogen) variants and mutations

AGT (also known as Angiotensinogen) is a human protein-coding gene encoding an angiotensinogen protein. It provides the precursor from which renin generates angiotensin I, placing it at the start of the renin-angiotensin system that regulates blood pressure and fluid balance. Rare variants can cause renal tubular dysgenesis, while common variation has been studied for effects on blood pressure. This analysis covers 848 AGT variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes primary hyperoxaluria type 1, primary hyperoxaluria, and alanine glyoxylate aminotransferase deficiency. Example AGT variants include A2T, P3S, and A4P.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.

Notable AGT variants

Examples include A2T, P3S, A4P, A4T, A4V, G5A, G5R, G5S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.